Monkeypox Virus

Monkeypox is caused by a Monkeypox virus that is closely linked to the smallpox virus and spreads through close contact between humans and animals. Monkeypox is only protected by smallpox immunization. Until this year, when more than 16,000 cases have been recorded from nonendemic nations, the global scientific community ignored the gradual rise in Monkeypox cases in Africa over the previous few decades. The WHO recently declared Monkeypox to be a public health emergency of global significance. The disease poses a greater hazard to the general population. The condition is distinguished by a brief febrile illness with lymphadenopathy followed by a rash that develops in phases of macules, papules, vesicles, and pustules before spreading centrifugally. Most cases recover within 2-4 weeks. Children, pregnant women, and immunocompromised people are more likely to experience complications. For high-risk groups, healthcare professionals, and close connections, vaccination with smallpox vaccines currently on the market is advised. Tecorivimat is an effective antiviral medication. A multifaceted approach is required to contain the Monkeypox outbreak, including increased surveillance, early diagnosis, isolation of infected patients, and immunization.